PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG

[1]  68Ga-Chloride PET Reveals Human Pancreatic Adenocarcinoma Xenografts in Rats—Comparison with FDG , 2009, Molecular Imaging and Biology.

[2]  S. Jalkanen,et al.  Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors. , 2009, Cancer research.

[3]  J. Knuuti,et al.  Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis. , 2009, Nuclear medicine and biology.

[4]  C. Nanni,et al.  Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  M. Saif,et al.  18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients. , 2008, Journal of gastrointestinal and liver diseases : JGLD.

[6]  N. Tamaki,et al.  Usefulness of 11C-Methionine for Differentiating Tumors from Granulomas in Experimental Rat Models: A Comparison with 18F-FDG and 18F-FLT , 2007, Journal of Nuclear Medicine.

[7]  S. Jalkanen,et al.  VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[8]  S. Jalkanen,et al.  68Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  F. Chierichetti,et al.  18-fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma , 2003, Journal of Gastrointestinal Surgery.

[10]  Hiroshi Fukuda,et al.  Comparison of18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation , 2006, Annals of nuclear medicine.

[11]  H. Fukuda,et al.  An experimental study onO-[18F]fluoromethyl-L-tyrosine for differentiation between tumor and inflammatory tissues , 2005, Annals of nuclear medicine.

[12]  H. Aro,et al.  Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  T. Saga,et al.  Dual-phase 18F-fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  W. Oyen,et al.  FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  A. van Waarde,et al.  Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  D. Adams,et al.  Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. , 2001, Journal of immunology.

[17]  K. Hirakawa,et al.  Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer. , 2001, International journal of oncology.

[18]  D. Visvikis,et al.  Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET , 2001, European Journal of Nuclear Medicine.

[19]  S. Jalkanen,et al.  Vascular Adhesion Protein 1 Mediates Binding of Immunotherapeutic Effector Cells to Tumor Endothelium1 , 2001, The Journal of Immunology.

[20]  R. Boellaard,et al.  Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  S. Jalkanen,et al.  VAP-1: an adhesin and an enzyme. , 2001, Trends in immunology.

[22]  S. Jalkanen,et al.  Vascular adhesion protein 1 (VAP‐1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  A. Nakao.  Oncological problems in pancreatic cancer surgery. , 2000, Nagoya journal of medical science.

[24]  S. Jalkanen,et al.  Cloning of  Vascular Adhesion Protein 1 Reveals a Novel Multifunctional Adhesion Molecule , 1998, The Journal of experimental medicine.

[25]  V. R. McCready,et al.  FDG accumulation and tumor biology. , 1998, Nuclear medicine and biology.

[26]  D. Adams,et al.  Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. , 1998, Journal of immunology.

[27]  Mark A. Stephenson,et al.  Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival , 1997, Cancer.

[28]  T Ido,et al.  High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  M. H. Tan,et al.  Characterization of a new primary human pancreatic tumor line. , 1986, Cancer investigation.

[31]  Michael E. Phelps,et al.  Quantitation in Positron Emission Computed Tomography , 1980 .

[32]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.